Carboplatin/pembrolizumab/pemetrexedAirway disease: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1983卷 / 1期

关键词：

D O I：

10.1007/s40278-023-49477-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：128 / 128

相关论文

共 50 条

[21] Carboplatin/pembrolizumab/pemetrexedLack of efficacy and pneumonitis : case report
Reactions Weekly, 2024, 2019 (1) : 105 - 105
[22] Carboplatin/pembrolizumab/pemetrexedRed marrow reconversion: case report
Reactions Weekly, 2022, 1930 (1) : 161 - 161
[23] Carboplatin/pembrolizumab/pemetrexedMultiple toxicities: case report.
Reactions Weekly, 2020, 1834 (1) : 64 - 64
[24] Carboplatin/pembrolizumab/pemetrexedCellulitis and pulmonary sarcoidosis: case report
Reactions Weekly, 2022, 1926 (1) : 155 - 155
[25] Pembrolizumab/carboplatin/paclitaxelArthralgia of the hands and lack of efficacy: case report
Reactions Weekly, 2022, 1927 (1) : 447 - 447
[26] Carboplatin/pembrolizumab/pemetrexedCOVID-19 pneumonia: case report
Reactions Weekly, 2021, 1845 (1) : 117 - 117
[27] Carboplatin/pembrolizumab/pemetrexedHepatitis and linear lichen planus: case report
Reactions Weekly, 2022, 1918 (1) : 131 - 131
[28] Carboplatin/pembrolizumab/pemetrexedTumour pseudoprogression and thyroid dysfunction: case report
Reactions Weekly, 2022, 1920 (1) : 140 - 140
[29] Carboplatin/pembrolizumab/pemetrexedAcute hepatitis E infection: case report
Reactions Weekly, 2023, 1977 (1) : 91 - 91
[30] Carboplatin/paclitaxel/pembrolizumabMyelosuppression, thrombocytopenia and acquired pembrolizumab resistance: case report
Reactions Weekly, 2020, 1810 (1) : 65 - 65

← 1 2 3 4 5 →